Hollencrest Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.9K | Hold |
360
| – | – | ﹤0.01% | 577 |
|
|
2025
Q1 | $29.2K | Hold |
360
| – | – | ﹤0.01% | 580 |
|
|
2024
Q4 | $32.4K | Sell |
360
-31
| -8% | -$2.79K | ﹤0.01% | 570 |
|
|
2024
Q3 | $38.6K | Sell |
391
-17
| -4% | -$1.68K | ﹤0.01% | 544 |
|
|
2024
Q2 | $37.8K | Hold |
408
| – | – | ﹤0.01% | 538 |
|
|
2024
Q1 | $38.7K | Hold |
408
| – | – | ﹤0.01% | 523 |
|
|
2023
Q4 | $36.4K | Buy |
408
+108
| +36% | +$9.64K | ﹤0.01% | 534 |
|
|
2023
Q3 | $21.9K | Hold |
300
| – | – | ﹤0.01% | 610 |
|
|
2023
Q2 | $25K | Hold |
300
| – | – | ﹤0.01% | 611 |
|
|
2023
Q1 | $22.9K | Hold |
300
| – | – | ﹤0.01% | 615 |
|
|
2022
Q4 | $24.9K | Buy |
+300
| New | +$24.9K | ﹤0.01% | 569 |
|
|
2018
Q3 | – | Sell |
-2,587
| Closed | -$247K | – | 354 |
|
|
2018
Q2 | $247K | Buy |
+2,587
| New | +$247K | 0.03% | 233 |
|